Icu Medical (ICUI) Stock
Infusion therapy and vascular access device manufacturer. Here's the price, business snapshot, and what's worth knowing about Icu Medical in August 2026.
ICU Medical Inc (ICUI) is a US-based medical device company that designs, manufactures and sells infusion therapy systems, vascular access devices and related consumables for hospitals and clinics. Investors should note that the business model combines durable capital equipment with recurring revenue from single-use disposables, which can support steady cash flows but is exposed to hospital purchasing cycles and reimbursement dynamics. Growth drivers include new product introductions, replacement demand, aftermarket consumables and selective acquisitions, while risks include regulatory approvals, competitive pressure from larger med-tech peers and possible margin volatility. The company operates in a highly regulated sector where quality and compliance are critical. Financial strength, pricing power and a stable installed base are key metrics to watch. This is general educational information, not personal financial advice — values can rise and fall and past performance is not a guide to future returns.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying ICU Medical's stock, with a target price suggesting significant growth potential.
Financial Health
ICU Medical is generating strong revenue and cash flow, with a solid profit margin.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Recurring consumable revenue
A steady stream of single‑use supplies can support predictable sales, though hospital purchasing cycles and pricing pressure may affect growth.
Regulatory and quality focus
Product approvals and compliance are essential in med‑tech; regulatory outcomes can materially influence performance and costs.
Market position and growth
New product launches and selective acquisitions can expand reach internationally, but competition from larger peers remains a consideration.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
